When a physician recommends IVIG therapy, patients often have questions about why it was prescribed, how long treatment takes, where it can be administered, whether insurance will cover it, and what side effects may occur.
IVIG stands for intravenous immunoglobulin. It is made from antibodies collected from donated human plasma and administered through a vein. For certain immune deficiencies, IVIG replaces antibodies the body does not produce effectively. For some autoimmune, neurologic, and inflammatory conditions, it may help modify an abnormal immune response.
| Have You Been Prescribed IVIG?
Mercy Infusion can help coordinate your physician’s order, benefits verification, prior authorization, treatment setting, and infusion schedule. |
What Is IVIG Therapy?
IVIG is a concentrated preparation of immunoglobulin G, or IgG, the most abundant antibody in the bloodstream. Plasma from many screened donors is pooled, purified, and processed into a sterile medication for intravenous administration.
A physician determines whether IVIG is appropriate, which product to use, the dose, frequency, infusion rate, monitoring requirements, and treatment setting. IVIG products are not identical; approved indications, age requirements, concentrations, ingredients, and prescribing instructions vary.
How Does IVIG Work?
Replacing Missing or Insufficient Antibodies
Patients with certain primary immune deficiencies may not produce enough effective antibodies. IVIG provides donor IgG antibodies to support immune function and may help reduce the frequency or severity of infections. This is often called immunoglobulin replacement therapy.
Modifying an Abnormal Immune Response
In autoimmune, inflammatory, and neurologic disorders, the immune system may attack healthy nerves, muscles, platelets, or other tissue. IVIG may help regulate harmful immune activity, interfere with damaging antibodies, reduce inflammation, or support neurologic and muscle function. The expected benefit and response timeline depend on the condition and treatment plan.
Who Is Eligible to Receive IVIG?
There is no universal symptom checklist. IVIG is a prescription therapy, and a qualified physician must determine medical appropriateness based on diagnosis, clinical history, test results, potential risks, and available alternatives.
- Supported diagnosis: documentation may include laboratory testing, immunoglobulin levels, nerve-conduction studies, platelet counts, infection history, examinations, and previous treatment records.
- Physician prescription: the order generally identifies the product, dose, frequency, infusion rate, treatment days, premedications, monitoring, and treatment setting.
- Appropriate product: each IVIG product has its own indications, age limits, formulation, contraindications, warnings, and instructions.
- Safety review: the clinical team reviews kidney disease, clotting history, cardiovascular risks, diabetes, previous reactions, IgA deficiency, medications, vaccinations, pregnancy, and current illness.
- Appropriate setting: home infusion is not suitable for every patient. Medical stability, reaction history, venous access, home environment, nursing availability, and insurance requirements all matter.
- Insurance medical necessity: coverage may require prior authorization, a confirmed diagnosis, testing, previous therapies, use of a preferred product, or an approved site of care.
| Need Help Starting Physician-Prescribed IVIG?
Mercy Infusion can coordinate with your physician and insurance plan to review the prescription, documentation, authorization, medication access, and treatment setting. |
What Conditions Does IVIG Treat?
IVIG is used for several immune, neurologic, autoimmune, and hematologic conditions. Not every product is approved for every diagnosis, and some clinically accepted uses may be off-label. The treating specialist determines whether IVIG is appropriate.
Primary Immunodeficiency and CVID
Patients with primary humoral immunodeficiency, including common variable immunodeficiency, may have low antibody levels and recurrent or unusually severe infections. IVIG can provide replacement IgG and ongoing immune support.
Chronic Inflammatory Demyelinating Polyneuropathy
CIDP is an immune-mediated disorder that damages peripheral nerves and may cause progressive weakness, numbness, reduced reflexes, balance problems, and difficulty walking. Selected IVIG products are approved for CIDP, and ongoing treatment is guided by strength, function, symptoms, and response.
Multifocal Motor Neuropathy
MMN is a rare immune-mediated neurologic disorder that often causes asymmetric weakness, particularly in the hands and arms. Certain IVIG products may be used to improve strength and disability in eligible adults.
Immune Thrombocytopenia and Dermatomyositis
IVIG may be used for selected patients with immune thrombocytopenia, a disorder involving low platelets and bleeding risk. A specific IVIG product is also approved for adult dermatomyositis, an inflammatory disease that can cause muscle weakness and a characteristic rash.
Guillain-Barré Syndrome and Myasthenia Gravis
IVIG is commonly used in acute Guillain-Barré syndrome and may be used for severe myasthenia gravis exacerbations or other specialist-directed situations. Rapidly worsening weakness, difficulty walking, swallowing problems, or breathing difficulty can be medical emergencies and require immediate evaluation rather than routine home or outpatient infusion.
Other Uses
Depending on the product and clinical circumstances, IVIG may also be used for Kawasaki disease, selected immune deficiencies, autoimmune neuropathies, inflammatory muscle disorders, and other rare immune-mediated conditions.
What Happens Before the First Infusion?
- Prescription and referral review: Mercy reviews the diagnosis, dose, frequency, clinical information, and requested setting.
- Benefits verification: the insurer is contacted regarding coverage, preferred products, network restrictions, site of care, and patient responsibility.
- Prior authorization: Mercy coordinates required records with the prescribing office and payer.
- Financial review: potential deductibles, copays, coinsurance, and assistance options are reviewed.
- Clinical review: the care team checks allergies, previous reactions, kidney and clotting history, medications, recent illness, and other risk factors.
- Treatment-setting selection: the physician, infusion provider, and insurer determine whether treatment should occur at home, in an infusion suite, or in another facility.
Learn more about copay assistance and the Mercy Infusion intake process.
How Should Patients Prepare?
- Confirm the appointment and expected duration
- Review medications and current symptoms with the care team
- Follow individualized hydration and food instructions
- Wear comfortable clothing
- Bring identification, insurance information, and a current medication list
- Plan for several hours if advised
- Arrange transportation when recommended
Patients should not stop medications, take extra medication, or change hydration practices without guidance from their healthcare team.
What Happens During an IVIG Infusion?
- Assessment: the nurse reviews symptoms, allergies, previous reactions, and vital signs.
- IV placement: a catheter is placed into a vein, usually in the hand or arm.
- Slow start: IVIG is commonly begun at a slower rate and increased as tolerated according to the order and product instructions.
- Monitoring: the nurse checks vital signs, the IV site, infusion rate, and symptoms throughout treatment.
- Completion: the IV is removed or cared for, and the patient receives follow-up instructions and information about future infusions.
Patients should immediately report headache, chills, flushing, nausea, back or chest discomfort, shortness of breath, rash, dizziness, or any sudden symptom. The nurse may slow or pause treatment and follow the prescribed reaction protocol.
How Long and How Often Is IVIG Given?
Many IVIG infusions take several hours. Duration depends on dose, patient weight, product concentration, rate limits, previous tolerance, medical risk, and whether the dose is divided across multiple days. Frequency also varies: some patients receive a short course, while others receive recurring maintenance infusions every few weeks or on another physician-directed schedule.
Common and Serious Side Effects
Commonly reported effects may include headache, fatigue, dizziness, nausea, chills, flu-like symptoms, and discomfort near the IV site. Some reactions improve when the infusion rate is adjusted under clinical direction.
Less common but serious risks may include blood clots, kidney injury, severe allergic reactions, aseptic meningitis, breakdown of red blood cells, or serious breathing complications. Patients should seek immediate care for chest pain, sudden shortness of breath, one-sided weakness, leg swelling, markedly reduced urination, severe headache with neck stiffness, facial or throat swelling, or other severe symptoms.
Can IVIG Be Given at Home?
Yes, some medically stable patients can receive IVIG at home with physician direction and trained nursing support. Eligibility depends on diagnosis, prescribed protocol, previous tolerance, medical risk, venous access, home environment, nursing availability, and insurance authorization. Patients requiring closer observation may be treated in Mercy Infusion’s ambulatory infusion suite or another clinical setting.
Compare home infusion and infusion-center care, or explore home infusion services and the Artesia infusion suite.
What Is the Difference Between IVIG and SCIG?
IVIG and subcutaneous immunoglobulin, or SCIG, both provide immunoglobulin but use different routes and schedules. IVIG is administered into a vein, usually in larger doses at longer intervals. SCIG is given under the skin in smaller amounts and is often administered more frequently.
Some patients with primary immunodeficiency or selected neurologic conditions may be candidates for either route, while other diagnoses are treated primarily with IVIG. Product indications, medical needs, lifestyle preferences, tolerance, and insurance coverage all influence the decision. A physician must determine which route and product are appropriate.
How Mercy Infusion Coordinates IVIG Therapy
Starting IVIG can involve the prescribing physician, specialty pharmacy, insurer, infusion nurse, treatment facility, and sometimes a financial-assistance program. Mercy Infusion helps connect those pieces so patients do not have to manage the process alone.
The team reviews the prescription and clinical documentation, verifies insurance benefits, coordinates prior authorization, confirms the prescribed product, arranges medication and supplies, schedules nursing or infusion-suite care, and explains what the patient can expect. For recurring therapy, Mercy also helps with authorization renewals, insurance changes, scheduling, and communication with the prescriber.
What Should Patients Report Before Treatment?
Before an infusion, patients should tell their physician and infusion team about kidney disease, diabetes, previous blood clots, cardiovascular risk factors, reduced mobility, pregnancy or breastfeeding, previous reactions to immunoglobulin, current medications and supplements, recent illness, and upcoming vaccinations.
These factors do not automatically mean IVIG cannot be used, but they may affect product selection, infusion rate, hydration instructions, laboratory monitoring, treatment setting, or the need for additional precautions. Patients should follow individualized guidance rather than changing medications or preparation routines on their own.
After the Infusion
Some patients feel well after treatment, while others experience headache, fatigue, nausea, chills, or other symptoms. The care team may provide instructions about hydration, activity, medications, laboratory testing, and when to call with concerns. Patients should follow the directions provided for their specific IVIG product and treatment plan.
Urgent symptoms such as chest pain, difficulty breathing, one-sided weakness, signs of a severe allergic reaction, markedly reduced urination, or severe headache with neck stiffness require immediate medical evaluation. This article does not replace the medication guide or prescribing information for the specific product.
Frequently Asked Questions
Does IVIG cure the condition?
IVIG is generally used to replace antibodies, control immune activity, stabilize function, or manage symptoms. It is not typically described as a cure.
How quickly does IVIG work?
Response varies by diagnosis. Some patients may notice improvement within days or weeks, while others require several cycles before the physician can evaluate effectiveness.
Is IVIG covered by insurance?
Many plans cover IVIG when medical-necessity requirements are met. Prior authorization, diagnostic documentation, preferred products, and site-of-care rules may apply.
Is financial assistance available?
Potential support depends on the product, insurance type, diagnosis, program rules, and funding. Mercy Infusion can help explore options, but eligibility cannot be guaranteed.
Are all IVIG brands the same?
No. Products differ in concentration, ingredients, approved uses, age requirements, rates, and precautions. Product selection should be directed by the physician and clinical pharmacy team.
| Start IVIG Therapy With Coordinated Support
Mercy Infusion helps coordinate the prescription, benefits review, prior authorization, medication access, nursing, and treatment setting. |
About the Author
April Cable, Senior Director of Operations
April Cable has more than 35 years of experience in specialty pharmacy billing, reimbursement, operations, and patient access. At Mercy Infusion, she helps patients and families navigate insurance requirements, prior authorization, financial-support programs, and specialty medication onboarding. Her work focuses on coordinating the people and information needed to move physician-prescribed therapy forward while keeping patients informed throughout the process.
This article is for general educational purposes and does not diagnose a condition, determine eligibility for IVIG, or replace individualized medical advice. IVIG products have different indications, warnings, dosing instructions, and protocols. Insurance coverage, treatment timing, response, financial assistance, and out-of-pocket costs cannot be guaranteed.
